BETA


2021/2154(DEC) 2020 discharge: Innovative Medicines Initiative Joint Undertaking (IMI)

Progress: Procedure completed

RoleCommitteeRapporteurShadows
Lead CONT CZARNECKI Ryszard (icon: ECR ECR) MARINESCU Marian-Jean (icon: EPP EPP), CREȚU Corina (icon: S&D S&D), WIEZIK Michal (icon: Renew Renew), RIVASI Michèle (icon: Verts/ALE Verts/ALE), KUHS Joachim (icon: ID ID), OMARJEE Younous (icon: GUE/NGL GUE/NGL)
Committee Opinion ENVI
Committee Opinion ITRE
Lead committee dossier:

Events

2022/10/05
   Final act published in Official Journal
2022/05/04
   EP - Debate in Parliament
2022/05/04
   EP - Decision by Parliament
Details

The European Parliament decided to grant discharge to the Executive Director of the Innovative Medicines Initiative 2 Joint Undertaking (now the Innovative Health Initiative Joint Undertaking) in respect of the implementation of its budget for the financial year 2020 and approve the closure of the Joint Undertaking’s accounts.

Noting that the Court of Auditors found that the annual accounts of the Joint Undertaking for the financial year 2020 present fairly the financial situation of the Joint Undertaking on 31 December 2020, as well as the results of its operations, Parliament adopted, by 572 votes to 37 with 37 abstentions, a resolution containing a series of observations which form an integral part of the discharge decision.

Budgetary and financial management

The final IMI2 Joint Undertaking available budget for 2020, including re-entered unused appropriations of previous years, assigned revenues, and reallocations to the next year, was EUR 276 538 561 in commitment appropriations (of which EUR 269 829 327 from the Union budget) and EUR 241 559 114 in payment appropriations (of which EUR 232 349 880 from the Union budget). The budget execution of the commitment appropriations and the payment appropriations reached 98.66 % and 97.08 %, respectively.

Members noted that out of the EUR 1 billion of contributions to be made by private members to operational activities of the IMI Joint Undertaking, by the end of 2020 the IMI Joint Undertaking had reported and validated in-kind and cash contributions of EUR 759 471 000 from private members, of which EUR 737 573 000 in-kind and EUR 21 898 000 in cash contributions. During 2020, 11 projects were running under the IMI Joint Undertaking, of which 3 had ended by 31 December 2020.

The IMI Joint Undertaking utilisation rate for payment appropriations for the Seventh Framework Programme projects was 96 %.

The Joint Undertaking concluded 19 new signed grant agreements, including 8 projects for the emergency call for proposals on coronavirus treatments and diagnostics.

Once again, Parliament called for a harmonisation of the calculation of in-kind contributions to the Joint Undertaking.

Other observations

The resolution also contains a series of observations on performance, staff and internal controls.

In particular, it noted the following:

- the IMI2 Joint Undertaking launched a fast-track call for proposals on coronavirus treatments and diagnostics, resulting in 8 projects. The Undertaking also launched three additional calls for proposals relating to topics such as rare diseases, infectious diseases, cancer, neurodegenerative diseases and autoimmune diseases;

- 19 new grant agreements for projects were signed with a total combined budget of over EUR 380 million, bringing the total IMI2 Joint Undertaking’s portfolio to 167 projects;

- an important contribution to the common European response to the COVID-19 pandemic was made by the Undertaking and it reallocated EUR 45 million of its 2020 budget to a fast-track call for proposals launched in March 2020;

- the issue of intellectual property rights needs to be addressed in all contracts;

- on 31 December 2020, 53 of the 56 positions in the staff establishment plan of the IMI2 Joint Undertaking were occupied, five positions were filled during 2020, three for temporary agents and two for contract agents;

- IMI2 set up reliable ex-ante control procedures for financial and operational desk reviews;

- systemic errors were found in the personnel costs declared by beneficiaries, in particular on the part of SMEs and new beneficiaries. Therefore, Parliament called on the Joint Undertaking should strengthen its internal control systems, given that SMEs and new beneficiaries are more error-prone.

Documents
2022/03/29
   EP - Committee report tabled for plenary, single reading
Documents
2022/03/29
   EP - Committee report tabled for plenary
Documents
2022/02/28
   EP - Vote in committee
2022/02/16
   CSL - Supplementary non-legislative basic document
Documents
2022/02/02
   EP - Amendments tabled in committee
Documents
2021/12/17
   EP - Committee draft report
Documents
2021/11/12
   CofA - Court of Auditors: opinion, report
2021/09/14
   EP - Committee referral announced in Parliament
2021/07/28
   EP - CZARNECKI Ryszard (ECR) appointed as rapporteur in CONT
2021/06/30
   EC - Non-legislative basic document
2021/06/30
   EC - Non-legislative basic document published

Documents

Votes

Décharge 2020: entreprise commune «Initiative en matière de médicaments innovants 2» - Discharge 2020: Innovative Medicines Initiative 2 Joint Undertaking - Entlastung 2020: Gemeinsames Unternehmen „Initiative Innovative Arzneimittel 2“ - A9-0072/2022 - Ryszard Czarnecki - Proposition de résolution (ensemble du texte) #

2022/05/04 Outcome: +: 572, -: 37, 0: 32
DE FR ES IT PL RO NL HU PT CZ SE BG BE IE AT DK HR SK LT EL LV FI SI CY LU MT EE
Total
88
67
56
72
47
26
27
18
21
19
20
13
20
13
18
14
12
12
10
17
8
13
7
6
6
5
6
icon: PPE PPE
158

Hungary PPE

1

Denmark PPE

For (1)

1

Latvia PPE

2

Slovenia PPE

3
2

Luxembourg PPE

2

Malta PPE

For (1)

1

Estonia PPE

For (1)

1
icon: S&D S&D
130

Czechia S&D

For (1)

1

Slovakia S&D

2

Lithuania S&D

2

Latvia S&D

2

Finland S&D

1

Slovenia S&D

2

Cyprus S&D

2

Luxembourg S&D

For (1)

1

Estonia S&D

2
icon: Renew Renew
95

Italy Renew

3

Poland Renew

1

Hungary Renew

2
3

Ireland Renew

2

Austria Renew

For (1)

1

Croatia Renew

For (1)

1

Lithuania Renew

1

Latvia Renew

For (1)

1

Finland Renew

3

Slovenia Renew

2

Luxembourg Renew

2

Estonia Renew

2
icon: Verts/ALE Verts/ALE
65

Spain Verts/ALE

3

Poland Verts/ALE

For (1)

1

Netherlands Verts/ALE

3

Portugal Verts/ALE

1

Czechia Verts/ALE

3

Sweden Verts/ALE

2

Belgium Verts/ALE

3

Ireland Verts/ALE

2

Austria Verts/ALE

3

Denmark Verts/ALE

2

Lithuania Verts/ALE

For (1)

1

Finland Verts/ALE

3

Luxembourg Verts/ALE

For (1)

1
icon: ECR ECR
57

Germany ECR

1

Netherlands ECR

4

Sweden ECR

Abstain (1)

3

Bulgaria ECR

1

Belgium ECR

2

Croatia ECR

1

Slovakia ECR

For (1)

1

Lithuania ECR

1

Greece ECR

Against (1)

1

Latvia ECR

2
icon: The Left The Left
37

Netherlands The Left

Abstain (1)

1

Portugal The Left

4

Czechia The Left

1

Sweden The Left

For (1)

1

Belgium The Left

Abstain (1)

1

Denmark The Left

Abstain (1)

1

Finland The Left

Abstain (1)

1

Cyprus The Left

2
icon: NI NI
38

France NI

2

Croatia NI

Abstain (1)

2

Slovakia NI

Against (1)

2

Lithuania NI

1

Latvia NI

1
icon: ID ID
61

Netherlands ID

Against (1)

1

Czechia ID

Against (2)

2

Austria ID

3

Denmark ID

Abstain (1)

1

Finland ID

2

Estonia ID

Against (1)

1
AmendmentsDossier
13 2021/2154(DEC)
2022/02/03 CONT 13 amendments...
source: 703.130

History

(these mark the time of scraping, not the official date of the change)

events/6
date
2022-10-05T00:00:00
type
Final act published in Official Journal
procedure/final
title
OJ L 258 05.10.2022, p. 0472
url
https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2022:258:TOC
procedure/stage_reached
Old
Procedure completed, awaiting publication in Official Journal
New
Procedure completed
docs/1
date
2021-11-12T00:00:00
docs
type
Court of Auditors: opinion, report
body
CofA
events/5/docs/0/url
https://www.europarl.europa.eu/doceo/document/TA-9-2022-0190_EN.html
docs/5
date
2022-05-04T00:00:00
docs
title: T9-0190/2022
type
Text adopted by Parliament, single reading
body
EP
events/5/summary
  • The European Parliament decided to grant discharge to the Executive Director of the Innovative Medicines Initiative 2 Joint Undertaking (now the Innovative Health Initiative Joint Undertaking) in respect of the implementation of its budget for the financial year 2020 and approve the closure of the Joint Undertaking’s accounts.
  • Noting that the Court of Auditors found that the annual accounts of the Joint Undertaking for the financial year 2020 present fairly the financial situation of the Joint Undertaking on 31 December 2020, as well as the results of its operations, Parliament adopted, by 572 votes to 37 with 37 abstentions, a resolution containing a series of observations which form an integral part of the discharge decision.
  • Budgetary and financial management
  • The final IMI2 Joint Undertaking available budget for 2020, including re-entered unused appropriations of previous years, assigned revenues, and reallocations to the next year, was EUR 276 538 561 in commitment appropriations (of which EUR 269 829 327 from the Union budget) and EUR 241 559 114 in payment appropriations (of which EUR 232 349 880 from the Union budget). The budget execution of the commitment appropriations and the payment appropriations reached 98.66 % and 97.08 %, respectively.
  • Members noted that out of the EUR 1 billion of contributions to be made by private members to operational activities of the IMI Joint Undertaking, by the end of 2020 the IMI Joint Undertaking had reported and validated in-kind and cash contributions of EUR 759 471 000 from private members, of which EUR 737 573 000 in-kind and EUR 21 898 000 in cash contributions. During 2020, 11 projects were running under the IMI Joint Undertaking, of which 3 had ended by 31 December 2020.
  • The IMI Joint Undertaking utilisation rate for payment appropriations for the Seventh Framework Programme projects was 96 %.
  • The Joint Undertaking concluded 19 new signed grant agreements, including 8 projects for the emergency call for proposals on coronavirus treatments and diagnostics.
  • Once again, Parliament called for a harmonisation of the calculation of in-kind contributions to the Joint Undertaking.
  • Other observations
  • The resolution also contains a series of observations on performance, staff and internal controls.
  • In particular, it noted the following:
  • - the IMI2 Joint Undertaking launched a fast-track call for proposals on coronavirus treatments and diagnostics, resulting in 8 projects. The Undertaking also launched three additional calls for proposals relating to topics such as rare diseases, infectious diseases, cancer, neurodegenerative diseases and autoimmune diseases;
  • - 19 new grant agreements for projects were signed with a total combined budget of over EUR 380 million, bringing the total IMI2 Joint Undertaking’s portfolio to 167 projects;
  • - an important contribution to the common European response to the COVID-19 pandemic was made by the Undertaking and it reallocated EUR 45 million of its 2020 budget to a fast-track call for proposals launched in March 2020;
  • - the issue of intellectual property rights needs to be addressed in all contracts;
  • - on 31 December 2020, 53 of the 56 positions in the staff establishment plan of the IMI2 Joint Undertaking were occupied, five positions were filled during 2020, three for temporary agents and two for contract agents;
  • - IMI2 set up reliable ex-ante control procedures for financial and operational desk reviews;
  • - systemic errors were found in the personnel costs declared by beneficiaries, in particular on the part of SMEs and new beneficiaries. Therefore, Parliament called on the Joint Undertaking should strengthen its internal control systems, given that SMEs and new beneficiaries are more error-prone.
procedure/subject/8.70.03.10
2020 discharge
docs/0
date
2021-06-30T00:00:00
docs
type
Non-legislative basic document
body
EC
docs/0
date
2021-06-30T00:00:00
docs
type
Non-legislative basic document
body
EC
docs/4
date
2022-03-29T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/A-9-2022-0072_EN.html title: A9-0072/2022
type
Committee report tabled for plenary, single reading
body
EP
docs/5
date
2022-05-04T00:00:00
docs
title: T9-0190/2022
type
Text adopted by Parliament, single reading
body
EP
events/0
date
2021-06-30T00:00:00
type
Non-legislative basic document published
body
EC
docs
events/0
date
2021-06-30T00:00:00
type
Non-legislative basic document published
body
EC
docs
events/3/docs
  • url: https://www.europarl.europa.eu/doceo/document/A-9-2022-0072_EN.html title: A9-0072/2022
events/4
date
2022-05-04T00:00:00
type
Debate in Parliament
body
EP
events/5
date
2022-05-04T00:00:00
type
Decision by Parliament
body
EP
docs
title: T9-0190/2022
forecasts
  • date: 2022-05-02T00:00:00 title: Indicative plenary sitting date
procedure/stage_reached
Old
Awaiting Parliament's vote
New
Procedure completed, awaiting publication in Official Journal
procedure/subject/8.70.03.10
2020 discharge
forecasts
  • date: 2022-05-02T00:00:00 title: Indicative plenary sitting date
forecasts
  • date: 2022-05-02T00:00:00 title: Indicative plenary sitting date
events/3
date
2022-03-29T00:00:00
type
Committee report tabled for plenary
body
EP
procedure/stage_reached
Old
Awaiting committee decision
New
Awaiting Parliament's vote
docs/3
date
2022-02-16T00:00:00
docs
title: 06005/2022
type
Supplementary non-legislative basic document
body
CSL
events/2
date
2022-02-28T00:00:00
type
Vote in committee
body
EP
docs/2/docs/0/url
https://www.europarl.europa.eu/doceo/document/CONT-AM-703130_EN.html
docs/2
date
2022-02-02T00:00:00
docs
title: PE703.130
type
Amendments tabled in committee
body
EP
forecasts
  • date: 2022-05-02T00:00:00 title: Indicative plenary sitting date
docs/1/docs/0/url
https://www.europarl.europa.eu/doceo/document/CONT-PR-698997_EN.html
docs/1
date
2021-12-17T00:00:00
docs
title: PE698.997
type
Committee draft report
body
EP
committees/0
type
Responsible Committee
body
EP
committee_full
Budgetary Control
committee
CONT
associated
False
rapporteur
name: CZARNECKI Ryszard date: 2021-07-28T00:00:00 group: European Conservatives and Reformists Group abbr: ECR
shadows
committees/0
type
Responsible Committee
body
EP
committee_full
Budgetary Control
committee
CONT
associated
False
rapporteur
name: CZARNECKI Ryszard date: 2021-07-28T00:00:00 group: European Conservatives and Reformists Group abbr: ECR
shadows
committees/1/opinion
False
events/1
date
2021-09-14T00:00:00
type
Committee referral announced in Parliament
body
EP
procedure/dossier_of_the_committee
  • CONT/9/06665
procedure/stage_reached
Old
Preparatory phase in Parliament
New
Awaiting committee decision
commission
  • body: EC dg: Budget commissioner: HAHN Johannes
committees/0
type
Responsible Committee
body
EP
committee_full
Budgetary Control
committee
CONT
associated
False
rapporteur
name: CZARNECKI Ryszard date: 2021-07-28T00:00:00 group: European Conservatives and Reformists Group abbr: ECR
shadows
committees/0
type
Responsible Committee
body
EP
committee_full
Budgetary Control
committee
CONT
associated
False
committees/2/opinion
False